5 Best Rated Penny Stocks to Buy According to Analysts
Germany-based Affimed is trading at $0.64 as of July 13, while its analyst price target is $6. This stock price target shows an upside potential of a whopping 837% from the current levels.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Octagon Capital Advisors Ting Jia | 1,917,995 | $7,978,859 | 0.97% | |
| 2. | Lynx1 Capital Management Weston Nichols | 993,913 | $4,134,678 | -5% | 0.84% |
| 3. | Alyeska Investment Group Anand Parekh | 798,000 | $3,319,680 | 0.01% | |
| 4. | Driehaus Capital Richard Driehaus | 787,700 | $3,276,832 | 0.02% | |
| 5. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 396,116 | $1,647,843 | 0.32% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.72 | 3,000 | $14,160.00 | 23,883 | 2025-12-16 | Filing | |
| $4.70 | 2,700 | $12,690.00 | 19,478 | 2025-12-16 | Filing | |
| $4.97 | 1,381 | $6,863.57 | 23,346 | 2025-12-15 | Filing | |
| $4.97 | 2,700 | $13,419.00 | 16,778 | 2025-09-26 | Filing | |
| $4.89 | 1,400 | $6,846.00 | 21,965 | 2025-09-22 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.84 | 20,559 | $78,946.56 | 243,392 | 2026-02-18 | Filing | |
| $3.84 | 8,149 | $31,292.16 | 125,883 | 2026-02-18 | Filing | |
| $3.84 | 4,925 | $18,912.00 | 56,457 | 2026-02-18 | Filing | |
| $3.84 | 4,925 | $18,912.00 | 121,926 | 2026-02-18 | Filing | |
| $4.17 | 34,799 | $145,111.83 | 196,154 | 2026-01-22 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,194,635 | $9,129,682 | 8.05% | |
| 2. | 2,138,603 | $8,896,588 | 0.01% | |
| 3. | 1,662,500 | $6,916,000 | 1.22% | |
| 4. | 1,066,050 | $4,434,768 | 0.07% | |
| 5. | 906,782 | $3,772,213 | 0% |